Age-Dependent Seroprevalence of JCV Antibody in Children.

Neuropediatrics 2016 Apr 19;47(2):112-4. Epub 2015 Oct 19.

Medical University of Innsbruck, Neurology, Innsbruck, Austria.

Progressive multifocal leukoencephalopathy (PML) is an opportunistic central nervous system infection, caused by the John Cunningham virus (JCV). PML may occur during treatment with immunosuppressive agents or monoclonal antibodies such as natalizumab. The JCV seroprevalence increases with age with a seropositivity of 60% in the adult human population. In this study, we analyzed sera from 109 pediatric multiple sclerosis (MS) patients (mean age 14 years) as well as sera from 162 patients with a wide range of suspected neurologic disorders (mean age 6.3 years). Our results showed a considerably lower seroprevalence for JCV in our pediatric cohort with 33.3% and equal distribution in both subgroups, compared with reported seropositivity in adult population. This could result in a lower risk for drug-induced PML in pediatric patients compared with adult patients and can influence the indication for natalizumab therapy in pediatric MS patients.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0035-1565272DOI Listing
April 2016

Publication Analysis

Top Keywords

age years
8
pediatric patients
8
seroprevalence jcv
8
patients
5
study analyzed
4
compared reported
4
population study
4
reported seropositivity
4
analyzed sera
4
sera 109
4
109 pediatric
4
jcv pediatric
4
pediatric
4
human population
4
adult human
4
increases age
4
pediatric cohort
4
jcv seroprevalence
4
natalizumab jcv
4
age seropositivity
4

Similar Publications